These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2931927)

  • 1. Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 May; 259(3):378-89. PubMed ID: 2931927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
    John JF; Twitty JA
    Antimicrob Agents Chemother; 1984 Nov; 26(5):781-4. PubMed ID: 6440481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
    Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli.
    Fass RJ; Helsel VL
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):77-81. PubMed ID: 3943292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci.
    Jones RN; Johnson DM; Barrett MS; Erwin ME
    J Chemother; 1991 Oct; 3(5):289-94. PubMed ID: 1809808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
    Hoogkamp-Korstanje JA; Meijer CA
    Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
    Marklein G; Häfelein J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):40-53. PubMed ID: 6277101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
    Vanhoof R; Nyssen HJ; Nulens E; Roebben E; Hubrechts JM
    Pathol Biol (Paris); 1990 Jun; 38(6):634-7. PubMed ID: 2165238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of ciprofloxacin against resistant clinical isolates.
    Kelley SG; Bertram MA; Young LS
    J Antimicrob Chemother; 1986 Mar; 17(3):281-6. PubMed ID: 2939048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.
    Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1098-100. PubMed ID: 2942105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P; Ryan DM; Sowa MA; Watts CM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
    Sun HK; Kuti JL; Nicolau DP
    Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compared sensitivities of 532 bacterial strains to six cephalosporins.
    Courtieu AL; Drugeon H
    Int J Clin Pharmacol Res; 1983; 3(3):195-201. PubMed ID: 6679522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    Pusztai-Markos Z; Pranada F
    Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effectiveness of aminoglycosides and cephalosporins in gram-negative rods.
    Vrbová E; Uxová M; Výmola F
    Czech Med; 1986; 9(3):148-52. PubMed ID: 3095073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.